MIAMI, FL - Opko Health Opko HealthLatest from The Business JournalsPhoto Gallery: Fast Tech AwardsForbes: 21 South Florida residents among America’s richestOpko sells ophthalmic instrument unit for .5MFollow this company has acquired Claros Diagnostics, a Woburn, Mass.-based company that has developed a novel blood testing kit for urology and infectious disease.

The Miami-based biotechnology and pharmaceutical company (NYSE: OPK) said Claros “presents an ideal strategic fit.”

Opko said it is developing unique antibody based tests for early diagnosis of Alzheimer’s disease; Parkinson’s disease; and lung, pancreatic and other cancers.

“The combined Opko-Claros technology will also provide an ideal platform for use as companion diagnostics,” the company stated.

Last month, Opko Health signed a deal to sell its ophthalmic instrumentation business to OPTOS for $17.5 million, plus future royalties.

Opko shares were down 13 cents to $4.68 in morning trading. The 52-week high was $5.03 on Feb. 16. The 52-week low was $2.41 on Oct. 18, 2010.

http://www.bizjournals.com/southflorida/news/2011/10/13/opko-acquires-claros-diagnostics.html?ed=2011-10-13&s=article_du&ana=e_du_pub